Bio Insight BioResources
Japan's off-year drug price revision stopped being a question of whether some time ago. When the health and finance ministers closed the FY2026 budget roun...
October 29, 2026 | Analysis
Every October, the same headline writes itself. India leads the count of US FDA warning letters to Asian drug plants, China follows, and the rest of the re...
October 21, 2026 | Analysis
If you are building a 2027 trial budget this month, you are probably working from a spreadsheet with one row per country and a column headed "start-up". Mo...
October 19, 2026 | News
Scientists have described eight MDPs: humanin, MOTS-c and six small humanin-like peptides (SHLP1 to SHLP6). Research has focused on different aspects of th...
October 12, 2026 | News
Most expansion projects stall or generate compliance gaps not because of technical failures but because purchasing preceded planning. Consumables ordered ...
October 12, 2026 | News
AT A GLANCE 12 generic makers with a public launch in India, selling 20 brands between them Rs 1,290 lowest stated monthly price, for vials...
October 09, 2026 | Analysis
Method in brief What counts. A CAR-T cell therapy approved on one of seven national registers: China's NMPA, Japan's PMDA and MHLW, Korea's MFDS, ...
October 08, 2026 | Analysis
Universities and public research institutes across the region are advancing research in cancer treatment, cell therapy, biologics and other emerging fields...
October 07, 2026 | Opinion | By Hajjerah TMK Hassan, Director, Discovery and Channels - ASEAN |Cytiva
So what is the real answer to the peptide vs protein question? It mostly comes down to size and shape. A peptide is a short chain of amino acids. A protein...
October 06, 2026 | News
What Is a Peptide? First, a quick look at what is being built. Amino acids are small building-block molecules, and living things use 20 standard ones to m...
October 06, 2026 | News
How this list was built Scope. Every biotech initial public offering with a first trading day between 1 January and 24 September 2026 on five venu...
September 29, 2026 | Analysis
Asia-Pacific’s New Drug Boom: 99 Approvals, 20 World Firsts Somewhere in the second week of January, a BeOne Medicines BCL2 inhibitor called sonroto...
September 23, 2026 | Analysis
A gerotherapeutic that delays five diseases by three years each would produce savings across five budget lines over thirty years, and a cost that lands in ...
September 04, 2026 | Analysis
With cooler weather, changing schedules, and renewed motivation, it's an ideal season to establish habits that can carry you through the holidays and beyon...
September 02, 2026 | News
Most Read
Bio Jobs
News